Article
images
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
PolyActiva secures $40 million AUD in Series C funding
3 Things You Should Know About Interventional Glaucoma Comanagement
EssilorLuxottica set to acquire Optegra clinics
Patient-Centered Treatment Strategies in the Management of nAMD and DME
HIV drug lamivudine shows promise in treating diabetic macular edema
Formosa Pharmaceuticals grants Harrow US commercial rights to clobetasol propionate ophthalmic suspension 0.05% (BYQLOVI), terminates deal with Eyenovia